Use of Tuftsin Bearing Nystatin Liposomes against an Isolate of Candida albicans showing Less In Vivo Susceptibility to Amphotericin B

By Khan* Masood A.   Syed* Faisal M.   Nasti* H.T.   Saima† K.   Haq W.   Shehbaz* A.   Owais* M.  

Journal of Drug Targeting, Vol. 11, Iss. 2, 2003-01 ,pp. : 93-99

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetics and Disposition of Various Drug Loaded Liposomes

By  

Current Drug Metabolism, Vol. 13, Iss. 4, 2012-05 ,pp. : 372-395

Bentham Science Publishers

Access to resources Recommend Favorite

Superior Chemotherapeutic Efficacy of Amphotericin B in Tuftsin-bearing Liposomes against Leishmania Donovani Infection in Hamsters

By Agrawal Ajay K.   Agrawal A.   Pal A.   Guru P.Y.   Gupta C.M.  

Journal of Drug Targeting, Vol. 10, Iss. 1, 2002-01 ,pp. : 41-45

Informa Healthcare

Access to resources Recommend Favorite

Niosomes as a potential drug delivery system for increasing the efficacy and safety of nystatin

By El-Ridy Mohammed Shafik   Abdelbary Ahmed   Essam Tamer   Abd EL-Salam Rania Mohsen   Aly Kassem Ahmed Alaa  

Drug Development and Industrial Pharmacy, Vol. 37, Iss. 12, 2011-12 ,pp. : 1491-1508

Informa Healthcare

Access to resources Recommend Favorite

Meloxicam: a reappraisal of pharmacokinetics, efficacy and safety

By Gates Brian J   Nguyen Trang T   Setter Stephen M   Davies Neal M  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 12, 2005-10 ,pp. : 2117-2140

Informa Healthcare

Access to resources Recommend Favorite